Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
K Pharma, Jan-Mar (1Q) Ordinary Profit Loss Narrows
4896 K Pharma,Inc. 【J-GAAP】
Earnings ReportK Pharma,Inc. <4896> [TSE Growth] announced its financial results at noon (11:30) on May 15th. The ordinary loss (non-consolidated) for the first quarter of the fiscal year ending December 2025 (January to March) was a reduced loss of 198 million yen (compared to a loss of 230 million yen in the same period last year).
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Mar, 2024 | 0 | -230 | -230 | -233 | -20.1 | ー | May 13, 2024 | J-GAAP |
Jan - Mar, 2025 | 0 | -198 | -198 | -199 | -17.2 | ー | May 15, 2025 | J-GAAP |
YoY | - | +13.9% | +13.9% | +14.6% | +14.7% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 0 | -423 | -422 | -426 | -36.8 | 0 | Aug 14, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | ー | -646 | -646 | -653 | -56.3 | 0 | Feb 13, 2025 | J-GAAP |
YoY | - | -52.7% | -53.1% | -53.3% | -53.1% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 1,000 | 366 | 344 | 260 | 25.4 | 0 | Feb 14, 2024 | J-GAAP |
Dec, 2024 | 0 | -836 | -836 | -846 | -72.9 | 0 | Feb 13, 2025 | J-GAAP |
Dec, 2025 Guidance | ー | -1,368 | -1,368 | -1,381 | -119.0 | 0 | Feb 13, 2025 | J-GAAP |
YoY | - | -63.6% | -63.6% | -63.2% | -63.1% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Mar, 2024 | 0 | -230 | -230 | -233 | -20.1 | -Inf | May 13, 2024 | J-GAAP |
Apr - Jun, 2024 | 0 | -193 | -192 | -193 | -16.7 | -Inf | Aug 14, 2024 | J-GAAP |
Jul - Sep, 2024 | 0 | -197 | -197 | -198 | -17.1 | -Inf | Nov 14, 2024 | J-GAAP |
Oct - Dec, 2024 | 0 | -216 | -217 | -222 | -19.1 | -Inf | Feb 13, 2025 | J-GAAP |
Jan - Mar, 2025 | 0 | -198 | -198 | -199 | -17.2 | -Inf | May 15, 2025 | J-GAAP |
YoY | - | +13.9% | +13.9% | +14.6% | +14.7% |
Related Articles
Fuva Brain Limited, 52% Increase in Ordinary Profit, Record High for The First Time in Eleven Years
Hammock, 7% Increase in Ordinary Profit, Update Record High for Fifth Consecutive Term, Dividend Raised by 10 yen
TODA, 10% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 1 yen, This Fiscal Year to Increase Dividend by 10 yen
NIKKEN KOGAKU, 15% Decrease in Ordinary Profit for The Current Fiscal Year
CHIKARANOMOTO, 15% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
AeroEdge, The Current Fiscal Year Ordinary Profit Revised Upward by 29%
Fujibo, 8% Increase in Ordinary Profit, Record High for The First Time in Nine Years, Dividend Raised by 20 yen
Matsuya R&D, 1% Increase in Ordinary Profit, Update Record High for Third Consecutive Term
YMIRLINK, Jan-Mar (1Q) Ordinary Profit Decreases by 3%
DYNIC, 7% Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Dividend Raised by 5 yen